Filed March 19, 2025

Serial No. 79426139

Examining Attorney null

Class Scientific research services in the fields of biochemistry, nucleic acids, and bioinformatics, excluding the field of cell culture product, in particular molecular biology techniques, especially antisense techniques; design of pharmaceutical active ingredients by the use of bioinformatics techniques; development of pharmaceutical products by the use of bioinformatics techniques being testing and diagnostic procedures; bioinformatic services for scientific research purposes in the pharmaceutical and biotechnological industry, namely, computational design and optimization of oligonucleotide sequences, sequence analysis of nucleic acids, target identification and validation using bioinformatic methods, in silico screening and prediction of efficacy, safety and off-target effects of nucleic acid therapeutics, analysis of gene expression and multiomics data, integration and analysis of biological data sets, selection of candidate oligonucleotides based on computational and experimental data, application of artificial intelligence and machine learning for drug discovery and sequence optimization, and scientific and technological services in the field of oligonucleotide research and nucleic acid therapeutics; evaluation of pharmaceutical products with respect to their safety and efficacy to assure compliance with industry standards; 100; 101; 100; 101; 100; 101

Case Type Service mark